- Admin
- #2,146
Offline
Just watch. Stay tuned. Like I said. Do some research and not just from some paid for sights. Dig deep and you may find gold bud.
Know this. They were only able to just begin selling their product in the U.S. as a FDA approved procedure as of January 2019. Their FDA approval for use on adults was just granted back in summer of 2018. They are only 3 reporting quarters into their sales of their product within the U.S. It is going to be a fun ride as I got in when they were on the OTC, at $1.06/share.
That's why I'm glad they're on the NASDAQ.. they'll finally have to do more reporting. The problem is that there is limited data. The idea of what they make is exciting. The question is, can they turn it into a profit and actually grow. The market is there, but can they deliver?